Inhalational agents are commonly used as anaesthetic agents during suction termination of pregnancy. Halothane, enflurane and isoflurane are all known to cause relaxation of isolated uterine muscle 1 in anaesthetic concentrations and therefore could increase blood loss. Clinical studies using halothane and enflurane show considerably higher blood loss than when techniques avoiding inhalation agents such as regional anaesthesia under paracervical block or general anaesthesia with thiopentone, pethidine/N 2 O were used 2 .
There are few published reports that assess blood loss in relationship to anaesthetic techniques in suction termination of pregnancy. One group studied methohexitone, fentanyl with intermittent methohexitone 3 , and enflurane anaesthesia 4 in women undergoing termination of pregnancy.
Propofol/isoflurane and propofol/alfentanil have been shown to provide satisfactory anaesthesia and are acceptable to women having terminations 5 . Propofol induction and maintenance is a suitable technique in suction termination 6 . No comparison, however, has been made of this technique with one using volatile anaesthetics for maintenance, with respect to blood loss during the procedure. The aim of this prospective randomized double-blind trial was to determine if blood loss during suction termination was influenced by avoiding a volatile agent altogether. Ethics committee approval was obtained for the study.
All ASA I and II women who presented for suction termination between the 6th and 14th week of pregnancy in Whangarei Area Hospital were assessed for entry to the trial. Women who had current vaginal bleeding, known bleeding disorders, abnormal platelet counts, and those who were on aspirin, NSAIDs or anticoagulants were excluded from the study. Women with severe hepatic renal, metabolic, cardiovascular or respiratory disorders or morbid obesity were also excluded.
Informed consent was obtained from each subject by one of the investigators and the patients were allocated to a treatment group by the toss of a coin, under strict conditions. (Two observers supervising the selections.) The size of the uterus was determined by prior ultrasound examination.
All patients were premedicated in the anaesthetic room with IV midazolam 20 µg/kg body weight and fentanyl 1.0 µg/kg body weight. The isoflurane group received an induction dose of propofol to disappearance of eyelash reflex and were maintained with N 2 O/O 2 and a concentration of isoflurane to achieve an end-tidal MAC of 1.1-1.2. Ventilation was initially assisted by hand. In the propofol group the same endpoint was achieved with a bolus of propofol and a propofol infusion was continued at a rate of 10 mg/kg/hr 7 . N 2 O/O 2 was added to the inhalation mixture. Ventilation was assisted as required and any movement of the patient was obtunded by 2 ml boluses of propofol. In all cases a facemask was used for anaesthesia and the whole procedure took less than ten minutes. Only one propofol infusion rate was required. No oxytocic was used. The anaesthetic was administered by the same anaesthetist in every case.
Blood loss during the procedure was collected into a calibrated bottle. Recording of the volume was done by a nurse who was unaware of the anaesthetic SHORT COMMUNICATION FIGURE 1: Boxplots showing distribution of blood loss during pregnancy termination using propofol and isoflurane. Isoflurane group mean loss 244 ml (95% CI 198, 301 ml). The propofol group mean blood loss 148 ml (95% CI 123, 177 ml) (t=3.54, df=97, P=0.001, O=outliers). the patient was receiving. The patient was followed up in recovery, where additional blood loss was measured by nursing staff who weighed the pads.
RESULTS
A comparison of the log transformed data between the two groups showed a highly significant difference in blood loss (t=3.54, df=97, P=0.001). The isoflurane group mean blood loss was 244 ml (95% CI 198-301) and the propofol group mean blood loss was 148 ml (95% CI 123-177) (Figure 1) . The blood loss difference remains highly significant when the comparison of difference between treatment groups is made controlling for the three confounders; age, weight and uterus size (t=4.1, df=94, P=0.0001).
Blood loss and the uterus size are also related (t=5.2, df=94, P=0.0001) with larger uteri being associated with greater blood loss ( Figure 2) .
DISCUSSION
It is a generally accepted fact that volatile anaesthetic agents reduce uterine tone during pregnancy. This is relevant in early as well as late pregnancy. As blood loss can be related to volatile anaesthetic concentration used during anaesthesia, it would be desirable to avoid using volatile agents by using a continuous infusion of an intravenous anaesthetic agent such as propofol.
Our technique of measurement of lost blood was not ideal. A colorimetric method would be preferable since this would avoid measuring the added volume of tissues other than blood extracted by suction. The method we used, however, was very simple, less timeconsuming and less expensive, therefore suiting the limited resources available to us.
The relevance of our clinical findings is that since most suction terminations are done as day-case procedures, a technique such as this which results in less bleeding would be more appropriate. 
